Genome-wide association study of bronchopulmonary dysplasia: a potential role for variants near the CRP gene

DSpace/Manakin Repository

Genome-wide association study of bronchopulmonary dysplasia: a potential role for variants near the CRP gene

Citable link to this page

 

 
Title: Genome-wide association study of bronchopulmonary dysplasia: a potential role for variants near the CRP gene
Author: Mahlman, Mari; Karjalainen, Minna K.; Huusko, Johanna M.; Andersson, Sture; Kari, M. Anneli; Tammela, Outi K. T.; Sankilampi, Ulla; Lehtonen, Liisa; Marttila, Riitta H.; Bassler, Dirk; Poets, Christian F.; Lacaze-Masmonteil, Thierry; Danan, Claude; Delacourt, Christophe; Palotie, Aarno; Muglia, Louis J.; Lavoie, Pascal M.; Hadchouel, Alice; Rämet, Mika; Hallman, Mikko

Note: Order does not necessarily reflect citation order of authors.

Citation: Mahlman, M., M. K. Karjalainen, J. M. Huusko, S. Andersson, M. A. Kari, O. K. T. Tammela, U. Sankilampi, et al. 2017. “Genome-wide association study of bronchopulmonary dysplasia: a potential role for variants near the CRP gene.” Scientific Reports 7 (1): 9271. doi:10.1038/s41598-017-08977-w. http://dx.doi.org/10.1038/s41598-017-08977-w.
Full Text & Related Files:
Abstract: Bronchopulmonary dysplasia (BPD), the main consequence of prematurity, has a significant heritability, but little is known about predisposing genes. The aim of this study was to identify gene loci predisposing infants to BPD. The initial genome-wide association study (GWAS) included 174 Finnish preterm infants of gestational age 24–30 weeks. Thereafter, the most promising single-nucleotide polymorphisms (SNPs) associated with BPD were genotyped in both Finnish (n = 555) and non-Finnish (n = 388) replication cohorts. Finally, plasma CRP levels from the first week of life and the risk of BPD were assessed. SNP rs11265269, flanking the CRP gene, showed the strongest signal in GWAS (odds ratio [OR] 3.2, p = 3.4 × 10−6). This association was nominally replicated in Finnish and French African populations. A number of other SNPs in the CRP region, including rs3093059, had nominal associations with BPD. During the first week of life the elevated plasma levels of CRP predicted the risk of BPD (OR 3.4, p = 2.9 × 10–4) and the SNP rs3093059 associated nominally with plasma CRP levels. Finally, SNP rs11265269 was identified as a risk factor of BPD (OR 1.8, p = 5.3 × 10−5), independently of the robust antenatal risk factors. As such, in BPD, a potential role for variants near CRP gene is proposed.
Published Version: doi:10.1038/s41598-017-08977-w
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571168/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:34491879
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters